Live Quote · NASDAQMTPHealthcare· Biotechnology

Midatech Pharma plc

$0.29 18.50%($-0.06)
TickerSpark Score
53/100
Mixed
100
Valuation
40
Profitability
10
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MTP research report →

52-Week Range0% of range
Low
$0.19
Current
$0.29
High
$20.80
Company Overviewwww.midatechpharma.com

About the company

Midatech Pharma plc is a pharmaceutical company focused on the research and development of drug delivery technologies and therapeutic solutions across the United Kingdom, Europe, and international markets. Its active pipeline includes MTX110, an investigational direct-delivery treatment for aggressive brain tumors such as diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme. Also in development are MTX114, a topical immunosuppressant for managing psoriasis; MTD211, an extended-release formulation of brexpiprazole for schizophrenia and as an adjunct for major depressive disorder; and MTD219, a long-acting version of tacrolimus designed to mitigate the risk of organ transplant rejection.

CEO
Stephen A. Stamp
IPO
2015
Employees
20
HQ
Cardiff, GB

Price Chart

-94.61% · this period
$3.24$1.69$0.13May 26Nov 25May 26
Valuation
Market Cap
$1.98M
P/E
-0.16
P/S
0.00
P/B
0.09
EV/EBITDA
0.79
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-55.81%
ROIC
-71.94%
Growth & Income
Revenue
$0 · -100.00%
Net Income
$-5,729,000 · 19.07%
EPS
$-11.57 · -405.24%
Op Income
$-9,199,000
FCF YoY
-83.88%
Performance & Tape
52W High
$20.80
52W Low
$0.19
50D MA
$1.50
200D MA
$6.83
Beta
1.22
Avg Volume
1.84M

Get TickerSpark's AI analysis on MTP

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
May 10, 11Kiley Quinn Thomasbuy1,000
Oct 6, 10ZIMMERMAN GIFFORD Rother0
Oct 6, 10TOTH TERENCE Jother0
Oct 6, 10SCHNEIDER WILLIAM Jother0
Oct 6, 10MARTIN LARRY Wother0
Oct 6, 10LAMB DAVID Jother0
Oct 6, 10EVANS JACKother0
Oct 6, 10Cook Margo L.other0
Oct 6, 10BREMNER ROBERT Pother0
Oct 6, 10Antosiewicz Cedric Hother0
Coverage · MTP

Our MTP coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on MTP yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate MTP report →
Internal Compare

Similar companies

Peers in the same neighborhood.